Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate

Journal of Lipid Research

Volumn 55, Issue 8, 2014, Pages 1730-1737

  Sutter, Iryna ^a,b   Park, Rebekka ^b,c   Othman, Alaa ^a,b   Rohrer, Lucia ^a,b   Hornemann, Thorsten ^a,b   Stoffel, Markus ^b,c   Devuyst, Olivier ^b   Von Eckardstein, Arnold ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c ETH ZURICH   (Switzerland)

Author keywords

Chloride proton exchanger ClC5; Cystinosin; High density lipoprotein; Kidney; Megalin

Indexed keywords

APOLIPOPROTEIN M; CYSTINOSIN; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MEMBRANE PROTEIN; PROTEIN CIC 5; SPHINGOSINE 1 PHOSPHATE; UNCLASSIFIED DRUG; APOM PROTEIN, MOUSE; LYSOPHOSPHOLIPID; SPHINGOSINE; SPHINGOSINE 1-PHOSPHATE;

ANIMAL CELL; ARTICLE; CELL TRANSPORT; CONTROLLED STUDY; ENDOCYTOSIS; ERYTHROCYTE; ERYTHROCYTE EFFUSION; FEMALE; HUMAN; HUMAN CELL; KIDNEY TUBULE ABSORPTION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN ISOLATION; PROTEIN URINE LEVEL; TRANSGENIC MOUSE; URINARY EXCRETION; WESTERN BLOTTING; WILD TYPE; ANALOGS AND DERIVATIVES; ANIMAL; GENETICS; KIDNEY TUBULE; METABOLISM;

ANIMALS; APOLIPOPROTEINS M; ERYTHROCYTES; KIDNEY TUBULES; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; MICE; MICE, KNOCKOUT; SPHINGOSINE;

EID: 84905038899     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M050021     Document Type: Article

References (33)

1. Fyrst, H., and J. D. Saba. 2010. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nat. Chem. Biol. 6: 489-497.
2. Hla, T., and A. J. Dannenberg. 2012. Sphingolipid signaling in metabolic disorders. Cell Metab. 16: 420-434.
3. Hornemann, T., and T. S. Worgall. 2013. Sphingolipids and atherosclerosis. Atherosclerosis. 226: 16-28.
4. Nishi, T., N. Kobayashi, Y. Hisano, A. Kawahara, and A. Yamaguchi. 2014. Molecular and physiological functions of sphingosine 1-phosphate transporters. Biochim. Biophys. Acta. 1841: 759-765.
5. Bode, C., S. C. Sensken, U. Peest, G. Beutel, F. Thol, B. Levkau, Z. Li, R. Bittman, T. Huang, M. Tolle, et al. 2010. Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. J. Cell. Biochem. 109: 1232-1243.
6. Ono, Y., M. Kurano, R. Ohkawa, H. Yokota, K. Igarashi, J. Aoki, M. Tozuka, and Y. Yatomi. 2013. Sphingosine 1-phosphate release from platelets during clot formation: close correlation between platelet count and serum sphingosine 1-phosphate concentration. Lipids Health Dis. 12: 20.
7. Kobayashi, N., N. Kobayashi, A. Yamaguchi, and T. Nishi. 2009. Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J. Biol. Chem. 284: 21192-21200.
8. Liu, X., S. L. Xiong, and G. H. Yi. 2012. ABCA1, ABCG1, and SR-BI: transit of HDL-associated sphingosine-1-phosphate. Clin. Chim. Acta. 413: 384-390.
9. Sattler, K., and B. Levkau. 2009. Sphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protection. Cardiovasc. Res. 82: 201-211.
10. Christoffersen, C., and L. B. Nielsen. 2013. Apolipoprotein M: bridging HDL and endothelial function. Curr. Opin. Lipidol. 24: 295-300.
11. Sevvana, M., J. Ahnstrom, C. Egerer-Sieber, H. A. Lange, B. Dahlback, and Y. A. Muller. 2009. Serendipitous fatty acid binding reveals the structural determinants for ligand recognition in apolipoprotein M. J. Mol. Biol. 393: 920-936.
12. Christoffersen, C., H. Obinata, S. B. Kumaraswamy, S. Galvani, J. Ahnstrom, M. Sevvana, C. Egerer-Sieber, Y. A. Muller, T. Hla, L. B. Nielsen, et al. 2011. Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M. Proc. Natl. Acad. Sci. USA. 108: 9613-9618.
13. Karuna, R., R. Park, A. Othman, A. G. Holleboom, M. M. Motazacker, I. Sutter, J. A. Kuivenhoven, L. Rohrer, H. Matile, T. Hornemann, et al. 2011. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism. Atherosclerosis. 219: 855-863.
14. Ohkawa, R., K. Nakamura, S. Okubo, S. Hosogaya, Y. Ozaki, M. Tozuka, N. Osima, H. Yokota, H. Ikeda, and Y. Yatomi. 2008. Plasma sphingosine-1-phosphate measurement in healthy subjects: close correlation with red blood cell parameters. Ann. Clin. Biochem. 45: 356-363. (Pubitemid 352031541)
15. Wolfrum, C., M. N. Poy, and M. Stoffel. 2005. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat. Med. 11: 418-422. (Pubitemid 40562332)
16. Faber, K., V. Hvidberg, S. K. Moestrup, B. Dahlback, and L. B. Nielsen. 2006. Megalin is a receptor for apolipoprotein M, and kidney-specific megalin-deficiency confers urinary excretion of apolipoprotein M. Mol. Endocrinol. 20: 212-218. (Pubitemid 43011682)
17. Christensen, E. I., H. Birn, T. Storm, K. Weyer, and R. Nielsen. 2012. Endocytic receptors in the renal proximal tubule. Physiology (Bethesda). 27: 223-236.
18. Aseem, O., B. T. Smith, M. A. Cooley, B. A. Wilkerson, K. M. Argraves, A. T. Remaley, and W. S. Argraves. 2014. Cubilin maintains blood levels of HDL and albumin. J. Am. Soc. Nephrol. 25: 1028-1036.
19. Wilmer, M. J., F. Emma, and E. N. Levtchenko. 2010. The pathogenesis of cystinosis: mechanisms beyond cystine accumulation. Am. J. Physiol. Renal Physiol. 299: F905-F916.
20. Devuyst, O., and R. V. Thakker. 2010. Dent's disease. Orphanet J. Rare Dis. 5: 28.
21. Nykjaer, A., D. Dragun, D. Walther, H. Vorum, C. Jacobsen, J. Herz, F. Melsen, E. I. Christensen, and T. E. Willnow. 1999. An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 96: 507-515. (Pubitemid 29106838)
22. Christensen, E. I., O. Devuyst, G. Dom, R. Nielsen, P. Van der Smissen, P. Verroust, M. Leruth, W. B. Guggino, and P. J. Courtoy. 2003. Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules. Proc. Natl. Acad. Sci. USA. 100: 8472-8477. (Pubitemid 36842569)
23. Nevo, N., M. Chol, A. Bailleux, V. Kalatzis, L. Morisset, O. Devuyst, M. C. Gubler, and C. Antignac. 2010. Renal phenotype of the cystinosis mouse model is dependent upon genetic background. Nephrol. Dial. Transplant. 25: 1059-1066.
24. Ohnsorg, P. M., L. Rohrer, D. Perisa, A. Kateifides, A. Chroni, D. Kardassis, V. I. Zannis, and A. von Eckardstein. 2011. Carboxyl terminus of apolipoprotein A-I (ApoA-I) is necessary for the transport of lipid-free ApoA-I but not prelipidated ApoA-I particles through aortic endothelial cells. J. Biol. Chem. 286: 7744-7754.
25. Bielawski, J., J. S. Pierce, J. Snider, B. Rembiesa, Z. M. Szulc, and A. Bielawska. 2009. Comprehensive quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods Mol. Biol. 579: 443-467.
26. Berdyshev, E. V., I. A. Gorshkova, J. G. Garcia, V. Natarajan, and W. C. Hubbard. 2005. Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry. Anal. Biochem. 339: 129-136. (Pubitemid 40342687)
27. Wang, S. S., O. Devuyst, P. J. Courtoy, X. T. Wang, H. Wang, Y. Wang, R. V. Thakker, S. Guggino, and W. B. Guggino. 2000. Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptormediated endocytosis. Hum. Mol. Genet. 9: 2937-2945. (Pubitemid 32000767)
28. Segrest, J. P., M. C. Cheung, and M. K. Jones. 2013. Volumetric determination of apolipoprotein stoichiometry of circulating HDL subspecies. J. Lipid Res. 54: 2733-2744.
29. Annema, W., and A. von Eckardstein. 2013. High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. Circ. J. 77: 2432-2448.
30. Frias, M. A., U. Lang, C. Gerber-Wicht, and R. W. James. 2010. Native and reconstituted HDL protect cardiomyocytes from doxorubicin-induced apoptosis. Cardiovasc. Res. 85: 118-126.
31. Zhang, X. Y., X. Dong, L. Zheng, G. H. Luo, Y. H. Liu, U. Ekstrom, P. Nilsson-Ehle, Q. Ye, and N. Xu. 2003. Specific tissue expression and cellular localization of human apolipoprotein M as determined by in situ hybridization. Acta Histochem. 105: 67-72. (Pubitemid 36313933)
32. Koch, A., J. Pfeilschifter, and A. Huwiler. 2013. Sphingosine 1-phosphate in renal diseases. Cell. Physiol. Biochem. 31: 745-760.
33. Raggi, C., A. Luciani, N. Nevo, C. Antignac, S. Terryn, and O. Devuyst. 2014. Dedifferentiation and aberrations of the endolysosomal compartment characterize the early stage of nephropathic cystinosis. Hum. Mol. Genet. 23: 2266-2278.